Merck Moves Forward with Plans for Vorapaxar Approval

Article

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.